https://www.cnn.com/2020/07/10/health/queens-antibody-testing-coronavirus/index.html
1. Within this cohort there should be those asymptomatic vs hospitalized. For those hospitalized there should be associated date(s). This hopefully will more accurately define the antibody levels and corresponding decay timeframe.
2. Scientists still need to prove what level of antibodies are sufficient to repel the virus. Also is there a level of antibodies where symptoms/impacts are still reduced but the virus isn’t completely repelled?
If the above populations are able to provide more clarity on the level and decay the next set of challenges are likely:
How accessible is antibody testing? How invasive is the test (blood draw only?)?
What is the scientific/commercialized capacity to scale the testing?
1. Within this cohort there should be those asymptomatic vs hospitalized. For those hospitalized there should be associated date(s). This hopefully will more accurately define the antibody levels and corresponding decay timeframe.
2. Scientists still need to prove what level of antibodies are sufficient to repel the virus. Also is there a level of antibodies where symptoms/impacts are still reduced but the virus isn’t completely repelled?
If the above populations are able to provide more clarity on the level and decay the next set of challenges are likely:
How accessible is antibody testing? How invasive is the test (blood draw only?)?
What is the scientific/commercialized capacity to scale the testing?
